Evolus (EOLS) Asset Utilization Ratio (2019 - 2026)
Evolus' (EOLS) quarterly Asset Utilization Ratio came in at 1.35 in Q1 2026, up 9.41% YoY from 1.24 in Q1 2025, and up 1.18% on a QoQ basis from 1.34 in Q4 2025.
Evolus (EOLS) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
Evolus (EOLS) has 8 years of Asset Utilization Ratio data on file, last reported at 1.35 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 9.41% year-over-year to 1.35 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.35 (up 9.41% YoY) and the FY2025 annual result came in at 1.3, up 2.63% from the prior year.
- Asset Utilization Ratio improved to 1.35 in Q1 2026, from 1.34 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.35 in Q1 2026 to a low of 0.51 in Q1 2022.
- A 5-year average of 1.03 and a median of 1.07 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 90.13% — and 2024, when it declined 2.25%.
- Tracing EOLS's Asset Utilization Ratio over 5 years: stood at 0.8 in 2022, then jumped by 41.21% to 1.13 in 2023, then rose by 1.77% to 1.15 in 2024, then rose by 15.95% to 1.34 in 2025, then grew by 1.18% to 1.35 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.35 (Q1 2026), 1.34 (Q4 2025), and 1.28 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 549.85 Mn | 504.68 Mn | 57.18 Mn | 1.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 |
| Mar 31, 2026 | 1.35 |
| Dec 31, 2025 | 1.34 |
| Sep 30, 2025 | 1.28 |
| Jun 30, 2025 | 1.26 |
| Mar 31, 2025 | 1.24 |
| Dec 31, 2024 | 1.15 |
| Sep 30, 2024 | 1.07 |
| Jun 30, 2024 | 1.03 |
| Mar 31, 2024 | 1.06 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | 1.10 |
| Jun 30, 2023 | 1.02 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.80 |
| Sep 30, 2022 | 0.69 |
| Jun 30, 2022 | 0.61 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.42 |
| Sep 30, 2021 | 0.38 |